01707nam a2200253 4500 ESSALUD 20260902130441.0 ta t pe ||||| |||| 00| 0 spa d BMG eng Tobias, Deirdre K. Autor 54368 Getting Serious about Tickborne Diseases — Shifting Research Priorities páginas: 1971-1973 The incidence of Lyme disease has steadily increased since the discovery of the causative agent, Borrelia burgdorferi, in 1982. In recent years, an estimated 500,000 cases have been diagnosed each year in the United States, resulting in nearly $1 billion in annual health care costs. Cases of other tickborne diseases, including anaplasmosis, babesiosis, and Powassan virus infection, have also increased (see graphs). Despite 40 years of research aimed at controlling Lyme disease, there are currently no available prevention methods that significantly reduce disease incidence in humans. Failure to address this epidemic is in part a result of the misdirection of research efforts, which have emphasized clinical disease and pathogen microbiology rather than the root cause of Lyme disease: the infected tick vectors in the environment, which remain uncontrolled. INFECCIONES BACTERIANAS 7357 MEDICAMENTOS, DISPOSITIVOS Y LA FDA 54223 INFECCIONES PARASITARIAS 54373 VACUNAS 8158 INFECCIONES VIRALES 53766 SALUD PÚBLICA GENERAL 54132 22717 22665 Massachusetts NEJM Group NEJM013 The New England Journal of Medicine ESSALUD 0028-4793 ARTICULOS 2026-08-28 sqb 22881 22881